PPAR and Liver Injury in HIV‐Infected Patients
Authors:
Open Access
- 1 January 2009
- journal article
- review article
- Published by Wiley in PPAR Research
- Vol. 2009 (1) , 906167
Abstract
Due to the introduction of active HIV antiretroviral treatment, AIDS‐related morbidity and mortality have markedly decreased and liver diseases are now a major cause of morbidity and mortality in HIV‐infected patients. Chronic liver injury encompasses a wide spectrum of diseases due to HCV and HBV coinfection, drug‐related toxicity, and NASH. HIV‐infected patients who are receiving treatment present with a high prevalence of metabolic complications and lipodystrophy. Those patients are at high risk of nonalcoholic fatty liver disease, the liver feature of the metabolic syndrome. This review will focus on (1) the liver injuries in HIV‐infected patients; (2) both the current experimental and human data regarding PPAR and liver diseases; (3) the interactions between HIV and PPAR; (4) the potential use of PPAR agonists for the management of HIV‐related liver diseases.Keywords
This publication has 76 references indexed in Scilit:
- Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy #Hepatology, 2009
- Potential Relationship between Hepatobiliary Osteopontin and Peroxisome Proliferator–Activated Receptor α Expression following Ethanol-Associated Hepatic Injury In Vivo and In VitroToxicological Sciences, 2008
- Human Immunodeficiency Virus (HIV)-1 Viral Protein R Suppresses Transcriptional Activity of Peroxisome Proliferator-Activated Receptor γ and Inhibits Adipocyte Differentiation: Implications for HIV-Associated LipodystrophyMolecular Endocrinology, 2008
- Interaction of ligands for the peroxisome proliferator‐activated receptor γ with the endocannabinoid systemBritish Journal of Pharmacology, 2007
- Altered hepatic expression of SREBP-1 and PPARγ is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patientsAIDS, 2006
- Silent non-alcoholic fatty liver disease—a clinical–histological studyJournal of Hepatology, 2004
- Delayed liver regeneration in peroxisome proliferator-activated receptor-α-null miceHepatology, 2002
- Factors participating in severe HCV-related liver disease in HIV/HCV co-infectionJournal of Hepatology, 2002
- Pioglitazone Prevents Early-Phase Hepatic Fibrogenesis Caused by Carbon TetrachlorideBiochemical and Biophysical Research Communications, 2002
- Diabetic KKAy mice exhibit increased hepatic PPARγ1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinedionesJournal of Hepatology, 2001